Sargent Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
769
+14
+2% +$7.6K 0.05% 182
2025
Q4
$437K Buy
+755
New +$427K 0.05% 170
2025
Q3
Sell
-724
Closed -$325K 218
2025
Q2
$325K Sell
724
-403
-36% -$168K 0.04% 185
2025
Q1
$561K Buy
1,127
+416
+59% +$225K 0.09% 137
2024
Q4
$395K Buy
711
+47
+7% +$25.8K 0.06% 159
2024
Q3
$411K Buy
664
+4
+0.6% +$2.37K 0.07% 136
2024
Q2
$365K Sell
660
-17
-3% -$9.74K 0.07% 142
2024
Q1
$393K Sell
677
-194
-22% -$109K 0.09% 131
2023
Q4
$462K Buy
871
+201
+30% +$97.3K 0.1% 130
2023
Q3
$339K Buy
+670
New +$357K 0.08% 146

Other funds holding TMO

Sargent Investment Group's TMO Position: Q1 2026 in Review

Sargent Investment Group increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q1 2026, buying an estimated $7.6K and bringing the position to 769 shares worth $378K. The position accounts for 0.05% of the portfolio, ranked #182.

Sargent Investment Group first reported a position in TMO in Q3 2023 and has held it in 10 quarters since. The position peaked at $561K in Q1 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sargent Investment Group held 769 shares of Thermo Fisher Scientific worth $378K as of Q1 2026.
  • Sargent Investment Group bought 14 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.6K.
  • Thermo Fisher Scientific made up 0.05% of Sargent Investment Group's portfolio in Q1 2026, its #182 holding.
  • Sargent Investment Group first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 10 quarters since.
  • Sargent Investment Group's Thermo Fisher Scientific position peaked at $561K in Q1 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.